TWOEquity · Weekly research terminal

4114

Synmosa Biopharma Corporation

TW Healthcare Drug Manufacturers - Specialty & Generic

Latest week
14 Aug 2026
Weekly close
29.80 TWD
Fair value
28.46 TWD
Next-week expectancy
Negative 44.68%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TWO · Equity · Taiwan

4114

Synmosa Biopharma Corporation

Healthcare Drug Manufacturers - Specialty & Generic

Synmosa Biopharma Corporation, a specialty pharmaceutical company, engages in the manufacturing and sales of various pharmaceuticals and medical devices in Taiwan, China, the United States, Canada, Thailand, Malaysia, Singapore, and internationally. It offers medicines for urology, hormones, oncology, dermatology, cardiovascular, CNS, gastrointestinal, and other areas; and effervescent tables, granules, and nasal sprays. The company is also involved in provision of cosmetics, veterinary drugs, chemical food additives, and beverages; wholesale retail of environmental …

Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
16,222,753,792
Fair value reference
28.46
Next-week expectancy
Negative · 44.68%

Over the latest 12 completed weeks ending 2026-08-14, 4114 rose 9.76%, moving from 27.15 to 29.80. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -28.36 and has improved across the 12-week window. Market Dynamics is 1.00 on the latest week. Next-week expectancy is negative at 44.68% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
29.80
12-Week Change
9.76%
Trend Signal
Inactive
Next-Week Expectancy
Negative 44.68%
Signal Weeks
0 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
29.80
12-Week Change
9.76%
Trend Signal
Inactive
Next-Week Expectancy
Negative 44.68%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-28.36
Market Dynamics
1.00

Over the latest 12 completed weeks ending 2026-08-14, 4114 rose 9.76%, moving from 27.15 to 29.80. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -28.36 and has improved across the 12-week window. Market Dynamics is 1.00 on the latest week. Next-week expectancy is negative at 44.68% based on similar historical setup states.

Industry Peers

Taiwan equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
6446 PharmaEssentia Corporation TAI 14 Aug 2026 1200.00 1550.00 1190.00 1500.00 25.00%
6932 Merdury Biopharmaceutical Corporation TWO 14 Aug 2026 5.13 8.63 5.01 6.02 17.35%
7829 Yoda Pharmaceuticals Inc. TWO 14 Aug 2026 39.85 46.35 39.85 44.90 12.67%
4747 Johnson Chemical Pharmaceutical Works Co., Ltd. TWO 14 Aug 2026 49.70 58.10 49.70 54.50 9.66%
6467 TAHO Pharma TWO 14 Aug 2026 114.00 130.00 114.00 125.00 9.65%
6621 UniPharma Co., Ltd. TWO 14 Aug 2026 11.00 11.95 10.60 11.65 5.91%
6539 DV Biomed Co., Ltd. TWO 14 Aug 2026 40.30 42.40 38.30 42.40 5.21%
4172 InnoPharmax Inc. TWO 14 Aug 2026 10.95 11.45 10.70 11.45 4.57%
1780 Allied Biotech Corporation TWO 14 Aug 2026 22.75 23.75 22.30 23.75 4.40%
6483 Original BioMedicals Co., Ltd. TWO 14 Aug 2026 13.50 14.10 13.50 14.05 4.07%
6785 Alar Pharmaceuticals Inc. TWO 14 Aug 2026 98.10 104.00 96.50 100.00 1.94%
3705 YungShin Global Holding Corporation TAI 14 Aug 2026 53.50 54.50 53.00 54.30 1.50%
7860 TEH SENG TWO 14 Aug 2026 71.20 74.00 68.50 72.00 1.12%
4108 PhytoHealth Corporation TAI 14 Aug 2026 11.15 11.25 10.90 11.25 0.90%
6576 Foresee Pharmaceuticals Co., Ltd. TWO 14 Aug 2026 79.00 80.70 78.70 79.70 0.89%
6677 Anxo Pharmaceutical Co., Ltd. TWO 14 Aug 2026 16.00 16.50 16.00 16.10 0.63%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context